Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
DRUG ELIMINATION
• Since it is more preferable to work with logarithms rather than natural logs, we can convert the above
formula into:
kelim × t
log C = log C 0 −
2.303
C0 lnC0
C lnC
Slope = -kelim/2.303
• Hence, if we know the elimination rate constant of a graph (via graphical interpretation), then we can easily work
out the half life of the drug.
• The half life of a drug can give us an indication of how long a drug will stay in the body.
• There are some drugs which are eliminated out of the body at a constant rate (i.e. independent of plasma
concentration). An example of such a drug is ethanol.
• These drugs are said to undergo zero order kinetics.
• For drugs which are metabolised, the liver modifies the drug so that it is more water soluble (more polar and less
toxic). The water soluble drug will be able to be filtered by the glomerulus and remain in the tubules rather than be
reabsorbed (because they are more polar – remember that unionised substances are more readily absorbed).
• The important processes of the kidney which are responsible for the excretion of a drug are:
• The GFR
• Tubular reabsorption
• A passive process occurring at the distal convoluted tubule
• Substances in the tubule are able to be reabsorbed into the blood (peritubular capillaries)
• The environment inside the tubule is very important in determining which drugs/substances will
be reabsorbed. Remember that unionised substances are absorbed better than ionised ones.
• The pH of the tubular fluid will determine whether or not acid or basic drugs filtered
through the glomerulus will be reabsorbed back into the blood. The normal urine pH is
in the range of 5 – 8. More on this later.
• Tubular secretion
• An active process occurring at the proximal convoluted tubule.
• Substances in the blood (peritubular capillaries) can be secreted into the tubules.
• If we rely solely on renal excretion to remove a drug, then the drug will have a very long half life in the
body (e.g. gentomycin).
Tubular reabsorption
• Occurs in the distal convoluted tubule
• What determines whether a drug will be reabsorbed after it has been filtered?
1. Lipid solubility of the drug
• The more lipid soluble, the easier the drug will be able to pass through the tubular cells
and back into the peritubular capillaries.
2. pKa of the drug
• The pKa of a drug gives a measure of how strong an acid or base is.
• A very strong acid has a very low pKa
• A strong acid readily gives away its H+ so that it will be mainly in its ionised
form.
• AH A- + H+
• A very strong base has a very high pKa
• A strong base readily accepts a H+ and so will exist mainly in its ionised form.
• B + H+ BH+
• Strong acids or bases will be largely unaffected by fluctuations in urine pH, and so they
will tend to exist predominantly in an ionised form. This is good for us if these drugs are
in the tubular fluid, because they will be prevented from being reabsorbed.
• log [unionised/ionised] = pKa – pH (for acids)
• log [unionised/ionised] = pH – pKa (for bases)
• Say we have a strong acid with a pKa of 1 and a strong base with a pKa
of 15. The normal urine pH is between 5 and 8.
• At an acidic urine pH of 4,
• log [unionised/ionised] = 1 – 4 = -3 (for acids)
• log [unionised/ionised] = 4 – 15 = -11 (for bases
By Duy Thai: www.geocities.com/d.thai 1997 Pharmacology Semester 1 page 3 of 6
BUT…..
• The urine pH can be made acidic (to increase excretion of basic drug) by diet (eating lots
of proteins).
• The urine pH can be made basic (to increase excretion of acidic drug) by administering
NaHCO3
Tubular secretion
• Occurs at the proximal convoluted tubule
• Uses a Tm system where drugs or endogenous substances can be secreted into the tubular fluid, often against
their concentration gradient.
• The drugs and endogenous substances can share the same transporter. So too can other drugs.
• Hence, to prolong a drugs life, we can prevent it from being secreted into the tubular fluid by giving
another drug which competes for its same transporter. E.g. Probenecid competes with penicillin,
thus prolonging the life of penicillin.
• Drugs bound to plasma proteins cannot be filtered at the glomerulus, but they can be secreted.
• This occurs because as the free drugs are filtered from the blood, more of the bound drug will
dissociate and hence the “new” free drugs which missed being filtered the first time round, will be
able to be secreted.
C u .Vu
Renal clearance =
Cp
Cu = Concentration of the drug in the urine
Vu = Urine flow rate
Cp = Concentration of the drug in plasma
By Duy Thai: www.geocities.com/d.thai 1997 Pharmacology Semester 1 page 4 of 6
• If the clearance of the drug is > GFR, then the drug has been actively secreted into the tubules
• If the clearance of the drug is < GFR, then the some of the drug has been reabsorbed
• If a drug relies heavily on the kidney for its clearance (e.g. gentomycin, digoxin), then renal function is
important and renal impairment is of utmost concern.
• Renal impairment can mean:
• Immature renal handling at birth
• Decline of renal function with age
• Renal disease
• If the drug is in very high concentrations in the kidneys, then crystallisation can occur in the tubules,
resulting in crystalluria.
• As urine flow rate increases, the extent of clearance is increased (fairly obvious)!
Biliary excretion
Excreted in faeces
Reabsorbed in enterohepatic
circulation (recycled)
• How does a drug enter the bile?
• Transport systems transport the drug from the plasma into the bile against a concentration gradient
(the concentration of drug in bile > concentration in plasma).
• There are separate processes for acids, bases and uncharged conjugated forms of drugs
• It is a saturable process
• Large molecular weight drugs may be subject to this type of transport.
Lungs
• Can be used to eliminate gases and volatile anesthetics
• Summary
• The elimination of a drug in the body depends if it is handled by the liver or kidney
• Need to know whether the function of either liver or kidney is compromised
• Effects of other drugs
• Their effect on the metabolism of drugs in the liver by:
• Induction of enzymes
• Inhibition of enzymes
CA CV
Organ
Q = flow of blood Q = flow of blood
By Duy Thai: www.geocities.com/d.thai 1997 Pharmacology Semester 1 page 5 of 6
• Organ clearance is essentially measuring the amount/concentration of drug entering an organ and
then measuring the amount/concentration leaving the organ. Usually, the amount/concentration
leaving the organ is less because a certain fraction has been cleared by the organ.
• Note that amount is equal to the concentration × volume (or flow, if we want a rate)
• We calculate the extraction ratio as being:
Therefore if C × Q, then:
Q(C A − CV ) C(Grams/ml) × Q(ml/min) = grams/min
• Cl =
CA = amount of drug per minute
• The total body clearance (systemic clearance) is the sum of the renal clearance and the organ clearance.
• You can work out the organ clearance and then the renal clearance and add the 2 together to give
you the total clearance of the drug.
• An alternative way is to use this simple formula:
Cls = Volume of distribution × elimination rate constant
= Vd × kelim
• This only works for a one compartment model (1st order kinetics)
renal clearance
• Fraction excreted unchanged =
Total clearance
hepatic clearance
• Fraction metabolised =
Total clearance
• e.g. The following data was obtained for a particular drug:
• If a drug is administered by slow infusion directly into the circulation, the concentration of the drug in the
plasma will rise in a slow curve until it reaches a plateau, after which the drug concentration will decline in
an exponential decay curve.
• If the drug is not administered continuously in a slow infusion, but given repeated doses, the concentrations
of the drug in the body will fluctuate much more, although the mean will still be essentially the same as the
continuous infusion.
• If the drug was given twice daily, then the maximum dosage will be much smaller than if the drug
was given once daily. Why? Because if the drug was given once daily, more of it will have been
eliminated between injections.
• However, you can see that sometimes the drug concentrations will drop below the minimum
effective level, and so the drugs will have no effect. More importantly, we need to consider that no
all of the drug will have been eliminated from the previous injection, and so any subsequent
injection will add to the concentration of drug still present. This will result in concentrations of
drug which will be higher than the toxic level, causing much harm.
• Drugs such as digitoxin, which has a toxic level very near to its therapeutic level, need to have the
concentration monitored very closely, because there is little margin for error.
• Sometimes a loading dose is given where a large bolus of drug is given to the desired concentration very
quickly and maintained at that level.